PHARMACEUTICAL COMPOSITION OF CHLORINE FOR TREATMENT OF RESPIRATORY VIRAL INFECTION
The present invention relates to a pharmaceutical composition of chlorine for treatment of respiratory viral infection. More particularly, the invention relates to the pharmaceutical composition of chlorine administered by inhalation for the treatment of viral infection associated with COVID and viral morbidities..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 30. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
DEO KESHAV [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-30, Last update posted on www.tib.eu: 2023-07-02, Last updated: 2023-07-08 |
|---|
| Patentnummer: |
US2021401876 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01527666X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01527666X | ||
| 003 | DE-627 | ||
| 005 | 20230708155837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01527666X | ||
| 035 | |a (EPA)US2021401876 | ||
| 035 | |a (EPA)78270376 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a DEO KESHAV |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PHARMACEUTICAL COMPOSITION OF CHLORINE FOR TREATMENT OF RESPIRATORY VIRAL INFECTION |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-30, Last update posted on www.tib.eu: 2023-07-02, Last updated: 2023-07-08 | ||
| 520 | |a The present invention relates to a pharmaceutical composition of chlorine for treatment of respiratory viral infection. More particularly, the invention relates to the pharmaceutical composition of chlorine administered by inhalation for the treatment of viral infection associated with COVID and viral morbidities. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a PANCHASARA DINESH R |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 30. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:30 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/78270376/publication/US2021401876A1?q=US2021401876 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 30 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 30 |c 12 | ||